Albertsons Companies, Inc. (NYSE:ACI) was downgraded to perform from outperform at RBC Capital, as the brokerage believes the upside case is already reflected in shares, noting that the company’s shares increased 59% since the start of the year compared to a 17% increase in the S&P 500.
Looking forward to the upcoming Q2 earnings day (Oct 18), analysts at RBC Capital anticipate another beat-and-raise quarter, mentioning that they are focused on forward gross margin commentary and expect increasing GM headwinds.
Despite moving to the sidelines, the analysts said they continue to positively view the turnaround efforts from the company’s management thus far and believe the long-term algorithm remains intact.
Symbol | Price | %chg |
---|---|---|
0LTM.L | 23328700000 | 0 |
AMRT.JK | 2330 | 0 |
3382.T | 2249 | 0 |
282330.KS | 121200 | 0 |
Albertsons Companies, Inc. (NYSE:ACI) is a prominent player in the grocery industry, operating a wide range of supermarkets across the United States. The company is known for its diverse product offerings, including groceries, pharmacy services, and other consumer goods. Albertsons competes with other major grocery chains like Kroger and Walmart, striving to maintain its market position through strategic initiatives and financial performance.
On April 15, 2025, ACI reported earnings per share (EPS) of $0.46, exceeding the estimated $0.40. This positive earnings surprise was highlighted during the company's Q4 2024 earnings conference call, which featured key executives like CEO Vivek Sankaran and CFO Sharon McCollam. Despite the EPS beat, the company's revenue of approximately $18.8 billion fell short of the estimated $24.7 billion, as noted by analysts from institutions such as Goldman Sachs and UBS.
Albertsons' revenue growth was primarily driven by its pharmacy business, which saw significant expansion. This growth contributed to the company's overall identical sales increase. However, the positive earnings report was overshadowed by guidance that did not meet consensus estimates, leading to a 5% decline in ACI's stock price early Tuesday. This indicates that investors may have concerns about the company's future performance despite the current earnings beat.
The company's financial health is a point of concern, with a debt-to-equity ratio of approximately 4.22. This high ratio suggests that Albertsons relies heavily on debt financing, which could pose risks if not managed properly. Additionally, the current ratio of about 0.93 indicates potential challenges in meeting short-term liabilities with available short-term assets, as highlighted by analysts from institutions like Wells Fargo and Bank of America.
During the earnings call, conducted in a listen-only mode until the Q&A session, Albertsons' strategic direction and financial performance were discussed. The presence of analysts from major financial institutions underscores the importance of the company's financial results and future outlook. Despite the challenges, Albertsons remains focused on leveraging its strengths in the pharmacy sector to drive growth and improve its financial position.
Albertsons Companies, Inc. (NYSE:ACI) is a prominent player in the grocery industry, operating a wide range of supermarkets across the United States. The company is known for its diverse product offerings, including groceries, pharmacy services, and other consumer goods. Albertsons competes with other major grocery chains like Kroger and Walmart, striving to maintain its market position through strategic initiatives and financial performance.
On April 15, 2025, ACI reported earnings per share (EPS) of $0.46, exceeding the estimated $0.40. This positive earnings surprise was highlighted during the company's Q4 2024 earnings conference call, which featured key executives like CEO Vivek Sankaran and CFO Sharon McCollam. Despite the EPS beat, the company's revenue of approximately $18.8 billion fell short of the estimated $24.7 billion, as noted by analysts from institutions such as Goldman Sachs and UBS.
Albertsons' revenue growth was primarily driven by its pharmacy business, which saw significant expansion. This growth contributed to the company's overall identical sales increase. However, the positive earnings report was overshadowed by guidance that did not meet consensus estimates, leading to a 5% decline in ACI's stock price early Tuesday. This indicates that investors may have concerns about the company's future performance despite the current earnings beat.
The company's financial health is a point of concern, with a debt-to-equity ratio of approximately 4.22. This high ratio suggests that Albertsons relies heavily on debt financing, which could pose risks if not managed properly. Additionally, the current ratio of about 0.93 indicates potential challenges in meeting short-term liabilities with available short-term assets, as highlighted by analysts from institutions like Wells Fargo and Bank of America.
During the earnings call, conducted in a listen-only mode until the Q&A session, Albertsons' strategic direction and financial performance were discussed. The presence of analysts from major financial institutions underscores the importance of the company's financial results and future outlook. Despite the challenges, Albertsons remains focused on leveraging its strengths in the pharmacy sector to drive growth and improve its financial position.
Albertsons Companies, Inc. (NYSE:ACI) is a major player in the grocery industry, operating numerous supermarket chains across the United States. The company competes with other large retailers like Kroger and Walmart. On January 8, 2025, ACI reported its earnings for the third quarter of 2024, revealing a revenue of approximately $18.77 billion, which was slightly below the estimated $18.93 billion.
The earnings call, held on the same day, featured key figures such as CEO Vivek Sankaran and CFO Sharon McCollam. Analysts from major financial institutions like JPMorgan and Wells Fargo participated, highlighting the significance of ACI's financial performance. Despite the revenue shortfall, the company's earnings exceeded expectations, leading to a rise in ACI's stock price.
ACI's financial metrics provide further insight into its market position. The company has a price-to-earnings (P/E) ratio of 11.07, indicating how the market values its earnings. Its price-to-sales ratio of 0.14 suggests a relatively low market valuation compared to its revenue, while the enterprise value to sales ratio of 0.32 reflects a modest enterprise value in relation to sales.
The company's financial health is also evident in its earnings yield of 9.03%, offering a glimpse into the return on investment for shareholders. However, ACI's debt-to-equity ratio is high at 4.22, indicating a significant level of debt compared to equity. The current ratio of 0.93 suggests that ACI has slightly less than enough current assets to cover its current liabilities, which could be a point of concern for investors.
Albertsons Companies, Inc. (NYSE:ACI) is a major player in the grocery industry, operating numerous supermarket chains across the United States. The company competes with other large retailers like Kroger and Walmart. On January 8, 2025, ACI reported its earnings for the third quarter of 2024, revealing a revenue of approximately $18.77 billion, which was slightly below the estimated $18.93 billion.
The earnings call, held on the same day, featured key figures such as CEO Vivek Sankaran and CFO Sharon McCollam. Analysts from major financial institutions like JPMorgan and Wells Fargo participated, highlighting the significance of ACI's financial performance. Despite the revenue shortfall, the company's earnings exceeded expectations, leading to a rise in ACI's stock price.
ACI's financial metrics provide further insight into its market position. The company has a price-to-earnings (P/E) ratio of 11.07, indicating how the market values its earnings. Its price-to-sales ratio of 0.14 suggests a relatively low market valuation compared to its revenue, while the enterprise value to sales ratio of 0.32 reflects a modest enterprise value in relation to sales.
The company's financial health is also evident in its earnings yield of 9.03%, offering a glimpse into the return on investment for shareholders. However, ACI's debt-to-equity ratio is high at 4.22, indicating a significant level of debt compared to equity. The current ratio of 0.93 suggests that ACI has slightly less than enough current assets to cover its current liabilities, which could be a point of concern for investors.
Albertsons Companies, Inc. (NYSE:ACI) is a prominent entity in the U.S. food and drug retail sector. It operates over 2,276 stores and 1,722 pharmacies under various well-known banners. The company also manages numerous distribution centers and manufacturing sites, making it a significant player in the industry. Albertsons competes with other major retailers like Kroger and Walmart.
The consensus price target for ACI's stock has shown an upward trend over the past year. A year ago, the average price target was $22.13, which increased to $22.5 in the last quarter and further rose to $24 in the last month. This suggests growing confidence among analysts in the company's stock performance. UBS analyst Mark Carden has set an even higher price target of $33, indicating a positive outlook.
This positive shift in the consensus price target could be attributed to strategic business decisions and improved financial performance. Albertsons is set to release its earnings soon, as highlighted by CNBC's Jim Cramer. This event, along with new economic data releases, is expected to impact the market significantly, despite being described as a "light week."
Albertsons is also recognized as a potential value stock, according to an analysis by Zacks. The Zacks Rank system focuses on earnings estimates and revisions to identify promising stocks. This analysis, along with trends in value, growth, and momentum, suggests that ACI could be a strong investment pick. Investors might find this trend encouraging, indicating potential growth and value in Albertsons Companies, Inc.'s stock.
Albertsons Companies, Inc. (NYSE:ACI) is a prominent entity in the U.S. food and drug retail sector. It operates over 2,276 stores and 1,722 pharmacies under various well-known banners. The company also manages numerous distribution centers and manufacturing sites, making it a significant player in the industry. Albertsons competes with other major retailers like Kroger and Walmart.
The consensus price target for ACI's stock has shown an upward trend over the past year. A year ago, the average price target was $22.13, which increased to $22.5 in the last quarter and further rose to $24 in the last month. This suggests growing confidence among analysts in the company's stock performance. UBS analyst Mark Carden has set an even higher price target of $33, indicating a positive outlook.
This positive shift in the consensus price target could be attributed to strategic business decisions and improved financial performance. Albertsons is set to release its earnings soon, as highlighted by CNBC's Jim Cramer. This event, along with new economic data releases, is expected to impact the market significantly, despite being described as a "light week."
Albertsons is also recognized as a potential value stock, according to an analysis by Zacks. The Zacks Rank system focuses on earnings estimates and revisions to identify promising stocks. This analysis, along with trends in value, growth, and momentum, suggests that ACI could be a strong investment pick. Investors might find this trend encouraging, indicating potential growth and value in Albertsons Companies, Inc.'s stock.
Albertsons Companies, Inc. (NYSE:ACI) is a major player in the U.S. food and drug retail sector. The company operates a vast network of 2,267 retail stores, 1,726 pharmacies, and 405 fuel centers across 34 states and the District of Columbia. Albertsons also manages 22 distribution centers and 19 manufacturing facilities, making it a significant force in the industry.
On January 8, 2025, ACI will release its quarterly earnings, with Wall Street anticipating an earnings per share of $0.66 and revenue of approximately $18.85 billion. The earnings release will be followed by a conference call at 8:30 a.m. Eastern Time, accessible through the company's investor relations page. A replay will be available for two weeks.
Albertsons' financial metrics provide insight into its market valuation. The company has a price-to-earnings (P/E) ratio of 11.39, reflecting how the market values its earnings. A price-to-sales ratio of 0.14 suggests a relatively low market valuation compared to its revenue, while the enterprise value to sales ratio of 0.32 indicates the company's total valuation in relation to its sales.
The enterprise value to operating cash flow ratio of 9.42 highlights Albertsons' cash flow generation relative to its valuation. An earnings yield of 8.78% offers a perspective on the return on investment for shareholders. However, a debt-to-equity ratio of 2.62 points to a higher level of debt compared to equity, which could be a concern for investors.
Albertsons' current ratio of 0.90 indicates its ability to cover short-term liabilities with short-term assets. This ratio suggests that the company may face challenges in meeting its short-term obligations, which is an important consideration for stakeholders.